CVS Health study highlights GLP-1 benefits and the affordability challenge

CVS Health · Company update · November 15, 2026

CVS Health published a study examining the clinical benefits of GLP-1 medications and the ongoing challenges regarding their affordability for patients and the healthcare system.

Read the article

AntSpace’s summary of CVS Health’s own announcement: read the original.

More updates from CVS Health